11/14/2024
8:00 PM | Redmile Group, LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:24 PM | BAKER BROS. ADVISORS LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
8:00 AM | Lynx1 Capital Management LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
11/05/2024
3:15 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:05 PM | Stoke Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:56 PM | Stoke Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
|
11/01/2024
3:50 PM | Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
3:16 PM | Stoke Therapeutics (Filer)
| Form S-3ASR | |
09/23/2024
3:22 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13D/A | |
09/23/2024
3:23 PM | Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
4:23 PM | Blue Horizon Enterprise Ltd (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:17 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:20 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G | |
06/20/2024
11:15 PM | Stoke Therapeutics (Filer)
| Form EFFECT | |
06/13/2024
3:06 PM | Stoke Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/07/2024
3:42 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:32 PM | Harrison Seth Loring (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:35 PM | Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:37 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:39 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:41 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:27 PM | Smith Julie (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:29 PM | Burstein Jennifer (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:16 PM | Krainer Adrian R. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:18 PM | LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:19 PM | Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:18 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:15 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:17 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:20 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:21 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:06 PM | Stoke Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024
3:08 PM | Stoke Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024
3:11 PM | Stoke Therapeutics (Filer)
| Form ARS | |
04/18/2024
3:16 PM | Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
3:18 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13D/A | |
04/17/2024
3:17 PM | Ezbon International Ltd (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad) One tiny company...
Could quickly become "the next SpaceX."
It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00.
Get urgent details inside this free report... The Next SpaceX Pre-IPO |
04/11/2024
3:06 PM | Stoke Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/03/2024
3:19 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:36 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
4:20 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
3:47 PM | Stoke Therapeutics (Filer)
| Form 424B5 | |
03/25/2024
3:03 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:07 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:07 PM | Stoke Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2024
7:29 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:30 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:31 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:34 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:36 PM | Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
9:36 AM | Cowen Financial Products LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G | |
02/26/2024
9:38 AM | Cowen Financial Products LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/15/2024
3:17 PM | Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:20 AM | Lynx1 Capital Management LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
6:44 AM | RTW INVESTMENTS, LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
1:51 PM | MORGAN STANLEY (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024
3:32 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:49 PM | Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:09 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
3:15 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:17 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:18 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:20 PM | Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
8:04 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
